a.methotrexate: dihydrofolate reductase
b.prednisolone: NFkB
c.cyclosporin: calcineurin
d.basiliximab: IL-2 receptor
e.OKT3: CD52
f.corticosteroid: Hsp90.
Multiple myeloma involves the unregulated proliferation of an antibody-producing plasma
cell (myeloma cell) independently of antigen stimulation or T-cell help. Myeloma cells
populate multiple sites in the bone marrow, where they produce immense quantities of
monoclonal immunoglobulin as well as suppressing normal marrow function. Myeloma
cells also synthesize and secrete excessive amounts of free light chains (known as
Bence-Jones protein), which, because of their low molecular weight (~25kDa) are excreted
as free light chains in the urine.
In a given patient the free light chains are both monoclonal and all are of either the or
the type.
A-Explain both of these observations.
B-Why do you think patients with multiple myeloma are more susceptible than normal to
pyogenic infections, such as pneumonia caused by Streptococcus pneumoniae or
Haemophilus influenzae?